| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.24 | 4e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |